A Xenograft Model for Venous Malformation

Area of Science:

• Vascular Biology
• Oncology
• Genetics

Background:

• Xenograft models are crucial for in vivo studies of cellular functions within a host microenvironment.
• Venous malformations (VM) are characterized by gene mutations in TIE2 and PIK3CA.
• Understanding VM pathogenesis requires effective in vivo models.

Purpose of the Study:

• To establish a novel xenograft model for venous malformations (VM).
• To utilize genetically modified human endothelial cells to recapitulate VM in vivo.
• To provide a tool for studying the cellular and molecular mechanisms of VM.

Main Methods:

• Generating a xenograft model using human umbilical vein endothelial cells (HUVEC) with a constitutively active TIE2 mutation (TIE2 p.L914F).
• Employing patient-derived endothelial cells (EC) with TIE2 and/or PIK3CA mutations.
• Subcutaneous injection of these EC into athymic nude mice to induce VM-like lesions.

Main Results:

• The generated xenograft model successfully recapitulates histopathological features of human VM tissue.
• Visible vascularization of lesion plugs containing TIE2/PIK3CA-mutant EC was observed within 7-9 days.
• The model allows for in vivo monitoring of cellular functions in the context of a host microenvironment.

Conclusions:

• This xenograft model provides an effective in vivo system for studying venous malformations.
• The rapid vascularization and recapitulation of VM features make it a valuable research tool.
• Further studies using this model can elucidate VM pathogenesis and inform therapeutic strategies.